Medtronic has announced that it has acquired combination product specialist Tyrx (Monmouth Junction, NJ) for $160 million. Tyrx, a spin-off from Rutgers University, was launched in 1998 to develop products to combat surgical-site infections ...
The early management of acute thoracolumbar spine and spinal cord injury is one of the most difficult tasks when treating trauma cases. To standardize the evaluation and treatment of acute thoracolumbar spinal injury, the Chinese ...
A vaccine normally used to thwart the respiratory illness tuberculosis also might help prevent the development of multiple sclerosis, a disease of the central nervous system, a new study suggests. In people who had a first episode of ...
The Ohio Third Frontier Commission, a state economic development initiative, recently approvedmore than $12.8 million in funds to promote cutting-edge biotechnology, including a neurostimulation device to enhance breathing and a spine ...
Boston Scientific has reported favorable results assessing real-world experience with the Precision Spectra spinal cord stimulator system. New retrospective data highlighting the Boston Scientific Precision Spectra spinal cord stimulator ...
US-based TYRX has obtained an approval from the US Food and Drug Administration (FDA) for expanded indications in marketing the AIGISRx N antibacterial envelope for use with spinal cord neuromodulators. Recently, TYRX has also obtained an ...
France-based Synapse Biomedical has obtained the Health Canada approval for its NeuRx diaphragm pacing system (DPS) for ventilator-dependent spinal cord injury (SCI) patients who lack voluntary control of their diaphragms. Synapse ...
Tags: Synapse Biomedical, Neurx DPS
Integra LifeSciences, an integrated medical technology company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its Integra laminoplasty system, a comprehensive set of implants and instruments designed for ...
The US Food and Drug Administration (FDA) has approved US-based StemCells’ investigational new drug (IND) application for clinical testing of its HuCNS-SC human neural stem cells as a treatment for spinal cord injury. StemCells is ...
Tags: Spinal Cord Injury, Medicine
Spinal Modulation has enrolled the first patient in ACCURATE study, a prospective, randomized, multi-center, controlled trial designed to evaluate the safety and efficacy of the Axium neurostimulator system for the treatment of chronic ...
Tags: Spinal Modulation, treatment
Medtronic, a US-based developer of medical devices, has introduced its new implantable neurostimulation systems, also called spinal cord stimulation (SCS) systems, for use in the treatment of chronic, intractable back and limb pain that are ...
Healthcare providers in the United States have preconceived notions about electronic health records-namely, that EHR systems haven't lived up to their promise of transforming healthcare by improving efficiency and cutting costs. The ...
US-based medical technology provider Boston Scientific has commenced a clinical trial to evaluate whether occipital nerve stimulation (ONS) using the Precision System can safely and effectively treat chronic migraine when used in ...
Spinal implants and instruments manufacturer Southern Spine has launched StabiLink MIS Spinal Fixation System. The FDA-approved and CE-marked minimally invasive system provides spinal fixation in lumbar fusion procedures, including the ...
US-based medical device manufacturer Boston Scientific has introduced fiXate Tissue Band in the US. The product, which was purchased from Anulex Technologies, is a suturing device that is designed to enable simple placement of a suture to ...
Tags: Boston Scientific, Fixate Tissue